10-K: AirSculpt Technologies Reports Revenue Decline in 2024, Focuses on Strategic Initiatives for Future Growth

AirSculpt Technologies experienced a revenue decline in 2024 and is implementing strategic initiatives, including optimizing marketing, enhancing sales, and expanding financing options, to drive future growth.

Summary

• AirSculpt Technologies, Inc. reported a revenue of $180.4 million for the year ended December 31, 2024, compared to $195.9 million for the year ended December 31, 2023, representing a decline of approximately 7.9%.
• The company performed 14,036 body contouring procedures in 2024.
• In January 2025, Yogi Jashnani was appointed as the new Chief Executive Officer to drive revenue growth through strategic initiatives.
• AirSculpt is focusing on optimizing marketing investments, enhancing sales strategies, expanding consumer financing options, and introducing new services, particularly in skin tightening.
• A cost reduction program is estimated to eliminate approximately $3 million in annual overhead costs and contracted expenses.
• The addressable market for body fat reduction procedures was estimated to be $11 billion in 2022 and is expected to grow at a 9% compound annual growth rate through 2027.
• The company had approximately $75.8 million in outstanding debt as of December 31, 2024.
• The company has a growing national footprint consisting of 32 centers across 20 U.S. states, Canada, and the United Kingdom as of March 14, 2025.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there are positive aspects such as the appointment of a new CEO and strategic initiatives for growth, the revenue decline and increased competition create uncertainty.

Positives

• The company is focusing on optimizing marketing investments, enhancing sales strategies, expanding consumer financing options, and introducing new services, particularly in skin tightening.
• A new CEO, Yogi Jashnani, was hired in January 2025 to spearhead revenue growth strategies.
• A cost reduction program is estimated to eliminate approximately $3 million in annual overhead costs and contracted expenses.

Negatives

• AirSculpt Technologies' revenue decreased by 7.9% in 2024, generating $180.4 million compared to $195.9 million in 2023.

Risks

• The company's operating results could be adversely affected if it is unable to successfully implement certain cost savings initiatives and revenue growth strategies.
• Macroeconomic trends including inflation and rising interest rates may adversely affect the company's financial condition and results of operations.
• The increased market acceptance, availability and customer awareness of weight-loss drugs has changed the market for body fat reduction procedures.
• The company faces competition for surgeons and other workers that provide medspa and cosmetic services.
• The company outsources the manufacturing of key elements of the tools used for AirSculpt procedures to a single third-party manufacturer, Euromi.
• The company's leverage could adversely affect its ability to raise additional capital to fund operations, limit its ability to react to changes in the economy or its industry and expose it to interest rate risk.

Future Outlook

AirSculpt is focusing on stabilizing revenue growth through optimizing marketing investment, improving go-to-market and sales strategies, expanding consumer financing offerings and focusing on new product innovation.

Management Comments

• Given the recent decline in revenue, our focus will be stabilizing revenue growth through optimizing our marketing investment, improving our go-to-market and sales strategies, expanding consumer financing offerings and focusing on new product innovation.
• We believe that Mr. Jashnani's industry knowledge, as well as his leadership experience, will provide value in driving initiatives forward to return to revenue growth.

Industry Context

The increased market acceptance, availability and customer awareness of weight-loss drugs has changed the market for body fat reduction procedures. The increasing use of weight loss drugs may lead to increased demand for body contouring and skin tightening procedures.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or comparable companies.
• The document does not provide specific details on global benchmarks.

Management Changes

Related Party Transactions

• We have entered into Continuity Agreements at all of our Professional Associations, with the exception of New York, with Dr. Rollins and the other Surgeon Owners, whereby they are the sole directors, officers, and owners of the Professional Associations.
• We have entered into, and may in the future enter into, agreements with our Sponsor which constitute related-party transactions as defined under Item 404 of Regulation S-K, as disclosed in further detail in this Annual Report on Form 10-K under the caption Certain Relationships and Related Transactions, and Director Independence.
• On March 12, 2025, in connection with the Third Amendment, the Company, SVB and our Sponsor (through certain affiliated entities) entered into that certain Limited Guarantee by and among Vesey Street Capital Partners Healthcare Fund, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., SVB and the Company (the Limited Guarantee), pursuant to which our Sponsor agreed to provide a $10.0 million guaranty of the Companys obligations under the Credit Agreement.

Stakeholder Impact

• The company's performance and strategic initiatives will impact shareholders, employees, customers, suppliers, and creditors.
• The company is focusing on expanding consumer financing options to enhance affordability, increase customer accessibility, and drive sales growth.

Next Steps

• The company intends to deliver long-term growth in revenue and profitability by executing on strategies to grow brand awareness, drive sales growth of centers, optimize marketing investment, and expand financing offerings.
• The company is focusing its marketing spend on techniques that have proven successful in the past using a returns-based approach and are also testing new areas such as online video, and other social marketing channels under the direction of our new Chief Digital Officer.
• The Company has also hired a new Chief Sales Officer dedicated to strengthening our consultative sales model with enhanced training, improving our sales processes, and providing a greater focus on lead conversion.
• The company has implemented a cost reduction program that is estimated to eliminate approximately $3 million in annual overhead costs and contracted expenses.

Key Dates